Inventor · disambiguated record
James M. Cook
Also filed as: COOK III JAMES M · COOK JAMES · COOK JAMES M
24 granted patents·18 pending applications·91 citations·filing 2003–2024
95Inventor score
Files withUWM RES FOUNDATION INC14COOK JAMES M8WISYS TECHNOLOGY FOUND INC5UNIV MARQUETTE4UNIV CINCINNATI3
Top patents by PatentIndex Score
42 records- 0190US7829709B1Cysteine prodrugs to treat schizophrenia and drug addictionUNIV MARQUETTE·Filed 2008·Granted Nov 9, 2010·9 cites·9 claims
- 0286US9006233B2Gabaergic receptor subtype selective ligands and their usesCOOK JAMES M·Filed 2012·Granted Apr 14, 2015·8 cites·3 claims
- 0385USRE47475ESelective agents for pain suppressionWISYS TECH FOUNDATION INC·Filed 2016·Granted Jul 2, 2019·4 cites·15 claims
- 0485US8173809B2Cysteine and cystine prodrugs to treat schizophrenia and reduce drug cravingsCOOK JAMES M·Filed 2009·Granted May 8, 2012·8 cites·7 claims
- 0584US8835424B2Selective agents for pain suppressionCOOK JAMES·Filed 2010·Granted Sep 16, 2014·14 cites·11 claims
- 0682US11753412B2Treatment of cognitive and mood symptoms in neurodegenerative and neuropsychiatric disorders with Alpha5-containing GABAA receptor agonistsUWM RES FOUNDATION INC·Filed 2020·Granted Sep 12, 2023·1 cites·46 claims
- 0782US9597342B2GABAergic receptor subtype selective ligands and their usesUWM RES FOUND INC·Filed 2015·Granted Mar 21, 2017·4 cites·1 claims
- 0882US7618958B2Stereospecific anxiolytic and anticonvulsant agents with reduced muscle-relaxant, sedative-hypnotic and ataxic effectsWISYS TECHNOLOGY FOUND INC·Filed 2005·Granted Nov 17, 2009·5 cites·9 claims
- 0982US7235656B2Anxiolytic agents with reduced sedative and ataxic effectsWISYS TECHNOLOGY FOUND INC·Filed 2006·Granted Jun 26, 2007·5 cites·8 claims
- 1079US12180216B2Treatment of cognitive and mood symptoms in neurodegenerative and neuropsychiatric disorders with alpha5-containing GABAA receptor agonistsUWM RES FOUNDATION INC·Filed 2023·Granted Dec 31, 2024·0 cites·12 claims
- 1179US8962692B2Cysteine and cystine prodrugs to treat schizophrenia and reduce drug cravingsCOOK JAMES M·Filed 2012·Granted Feb 24, 2015·4 cites·7 claims
- 1279US7119196B2Anxiolytic agents with reduced sedative and ataxic effectsWISYS TECHNOLOGY FOUND INC·Filed 2003·Granted Oct 10, 2006·12 cites·5 claims
- 1378US10259815B2Gabaergic ligands and their usesUWM RES FOUNDATION INC·Filed 2016·Granted Apr 16, 2019·4 cites·22 claims
- 1478US7595395B2Gabaergic agents to treat memory deficitsWISYS TECHNOLOGY FOUNDATION·Filed 2006·Granted Sep 29, 2009·5 cites·1 claims
- 1578US2025179080A1Treatment of cognitive and mood symptoms in neurodegenerative and neuropsychiatric disorders with alpha5-containing gabaa receptor agonistsUWM RES FOUNDATION INC·Filed 2024·Application pending·0 cites
- 1677US8268854B2Aza-beta-carbolines and methods of using sameCOOK JAMES M·Filed 2009·Granted Sep 18, 2012·4 cites·18 claims
- 1772US10906909B2Treatment of cognitive and mood symptoms in neurodegenerative and neuropsychiatric disorders with ALPHA5-containing GABAA receptor agonistsUWM RES FOUNDATION INC·Filed 2017·Granted Feb 2, 2021·1 cites·7 claims
- 1867US12054491B2Substituted benzo[f]imidazo[1,5-a][1,4]diazepines as GABA(a) receptor modulatorsUWM RES FOUNDATION INC·Filed 2022·Granted Aug 6, 2024·0 cites·12 claims
- 1966US10865203B2Ligands selective to alpha 6 subunit-containing GABAA receptors and their methods of useUWM RES FOUNDATION INC·Filed 2016·Granted Dec 15, 2020·1 cites·2 claims
- 2063US2025236597A1Deuterated benzodiazepine analogs and methods of use in treating cancerUNIV CINCINNATI·Filed 2023·Application pending·0 cites
- 2162US11427582B2Ligands selective to alpha 6 subunit-containing GABAA receptors and their methods of useUWM RES FOUNDATION INC·Filed 2020·Granted Aug 30, 2022·0 cites·2 claims
- 2262US2025313537A1Benzodiazepine analogs and methods of use in treating cancerUNIV CINCINNATI·Filed 2023·Application pending·0 cites
- 2362US2008108605A1Anxiolytic agents with reduced sedative and ataxic effectsWISYS TECHNOLOGY FOUND INC·Filed 2007·Application pending·0 cites
- 2461US8530512B2Broad spectrum gram-positive antimicrobials and anthelmintics with efficacy against drug-resistant strains and Mycobacterium speciesMONTE AARON P·Filed 2010·Granted Sep 10, 2013·2 cites·13 claims
- 2561US2007299058A1Anxiolytic Agents With Reduced Sedative And Ataxic EffectsWISYS TECHNOLOGY FOUND INC·Filed 2007·Application pending·0 cites
- 2658US2010004226A1Stereospecific anxiolytic and anticonvulsant agents with reduced muscle-relaxant, sedative-hypnotic and ataxic effectsCOOK JAMES M·Filed 2009·Application pending·0 cites
- 2758US2024293425A1Bzd-1 as a chemosensitizer of cancerUNIV CINCINNATI·Filed 2022·Application pending·0 cites
- 2857US2024374612A1Imidazobenzodiazepines for treatment of cognitive and mood symptomsUWM RES FOUNDATION INC·Filed 2022·Application pending·0 cites
- 2953US8435997B2Cysteine prodrugs to treat schizophrenia and drug addictionCOOK JAMES M·Filed 2010·Granted May 7, 2013·0 cites·10 claims
- 3053US2024279232A1Use of substituted 5-(4-methyl-6-phenyl-4h-benzo[f]imidazo[1,5-a][1,4] diazepin-3-yl)-1,2,4-oxadiazoles in the treatment of inflammatory conditionsUWM RES FOUNDATION INC·Filed 2021·Application pending·0 cites
- 3152US2010130481A1Anticonvulsant and anxiolytic methods of using receptor subtype selective agentsCOOK JAMES M·Filed 2010·Application pending·0 cites
- 3250US2022079952A1Uses of Radiation and Benzodiazepine Derivatives in Cancer TherapiesUNIV EMORY·Filed 2020·Application pending·0 cites
- 3350US2010048587A1Cysteine and cystine bioisosteres to treat schizophrenia and reduce drug cravingsUNIV MARQUETTE·Filed 2009·Application pending·0 cites
- 3449US9133141B2Cysteine and cystine bioisosteres to treat schizophrenia and reduce drug cravingsUNIV MARQUETTE·Filed 2014·Granted Sep 15, 2015·0 cites·9 claims
- 3547US11447495B2Substituted benzo[f]imidazo[1,5-a][1,4]diazepines as GABA(a) receptor modulatorsUWM RES FOUNDATION INC·Filed 2017·Granted Sep 20, 2022·0 cites·18 claims
- 3647US2010130479A1Gabaergic Agents to Treat Memory DeficitsCOOK JAMES M·Filed 2009·Application pending·0 cites
- 3747US2019300534A1Gabaergic ligands and their usesUWM RES FOUNDATION INC·Filed 2019·Application pending·0 cites
- 3845US2020316087A1Novel combination therapy for anxiety disorders, epilepsy, and painUWM RES FOUNDATION INC·Filed 2018·Application pending·0 cites
- 3945US2015175559A1Cysteine and cystine prodrugs to treat schizophrenia and reduce drug cravingsUNIV MARQUETTE·Filed 2015·Application pending·0 cites
- 4038US9879020B2GABAA agonists and methods of using to control airway hyperresponsiveness and inflammation in asthmaUWM RES FOUNDATION INC·Filed 2013·Granted Jan 30, 2018·0 cites·10 claims
- 4133US2010261711A1Selective anticonvulsant agents and their usesWISYS TECHNOLOGY FOUNDATION·Filed 2010·Application pending·0 cites
- 4230US2007292545A1Anti-infective agents and methods of useMONTE AARON·Filed 2007·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →